SignalKorea

SAMSUNG BIOLOGICS TO RAISE W3TR IN RIGHTS ISSUE FOR PEPTIDE MAKER DEAL - KOREAHERALD

Rights issue raises W3tr, funding peptide maker acquisition, signaling major capital deployment.

What changed

Rights issue raises W3tr, funding peptide maker acquisition, signaling major capital deployment.

Why it matters

Rights issue raises W3tr, funding peptide maker acquisition, signaling major capital deployment. — impact context not separately stored; see What changed.

Sources

koreaherald